Trimbow (beclomethasone dipropionate, formoterol fumarate, glycopyrrolate)
New combination
- Region
- 🇺🇸 US
- Active substance
- beclomethasone dipropionate, formoterol fumarate, glycopyrrolate
- Company
- Chiesi
- Status
- Approved
- FDA approval
- Thu 14 May 2026
- Designations
- New combination
- Application
- NDA219622
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Thu 14 May 2026🇺🇸 FDA approval
FDA approves Trimbow (beclomethasone dipropionate, formoterol fumarate, glycopyrrolate): new combination
Chiesi; NDA219622; New combination; aerosol, metered · source
Same substance in other markets
- 🇪🇺 orBec Application withdrawn · DOR BIOPHARMA UK Ltd
Follow Trimbow
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.